We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report.
This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search.
| Biotechnology | ||
| Acquirer | Target | Price |
| Denali Therapeutics Inc. | F-star Gamma Ltd. | $24 million |
| Zai Lab Limited | Exclusive worldwide license to protein therapeutics | N/A |
| eHealth | ||
| Acquirer | Target | Price |
| ResMed Inc. | HEALTHCAREfirst | N/A |
| Aquiline Capital Partners | Aspirion Health Resources | N/A |
| Laboratories, MRI and Dialysis | ||
| Acquirer | Target | Price |
| Myriad Genetics, Inc. | Counsyl, Inc. | $375 million |
| Managed Care | ||
| Acquirer | Target | Price |
| WellCare Health Plans, Inc.
|
Meridian | $2.5 billion |
| Pharmaceuticals | ||
| Acquirer | Target | Price |
| Newsoara Biopharma Co., Ltd. | Exclusive rights to PDE4 inhibitor program in China | N/A |
| Acerus Pharmaceuticals Corporation | Exclusive rights to SHACT | N/A |
| Link Health Group LTD | Exclusive license to Lidoderm in China | N/A |
| Physician Medical Groups | ||
| Acquirer | Target | Price |
| Revelstoke Capital Partners | Cincinnati Eye Institute | N/A |
| Other | ||
| Acquirer | Target | Price |
| Linden Capital Partners | Evolution Research Group, LLC | N/A |
